198 related articles for article (PubMed ID: 15895444)
1. Perioperative adjunctive treatment in the management of operable gastric cancer.
Silberman H
J Surg Oncol; 2005 Jun; 90(3):174-86; discussion 186-7. PubMed ID: 15895444
[TBL] [Abstract][Full Text] [Related]
2. TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG).
Leong T; Smithers BM; Michael M; Gebski V; Boussioutas A; Miller D; Simes J; Zalcberg J; Haustermans K; Lordick F; Schuhmacher C; Swallow C; Darling G; Wong R
BMC Cancer; 2015 Jul; 15():532. PubMed ID: 26194186
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant and neoadjuvant therapy for gastric cancer.
Kelsen DP
Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemoradiotherapy with or without intraoperative radiotherapy for the treatment of resectable locally advanced gastric adenocarcinoma.
Zhang Q; Tey J; Peng L; Yang Z; Xiong F; Jiang R; Liu T; Fu S; Lu JJ
Radiother Oncol; 2012 Jan; 102(1):51-5. PubMed ID: 22178689
[TBL] [Abstract][Full Text] [Related]
5. [Value of postoperative radiochemotherapy with 5-fluorouracil plus leucovorin in stage IB-IV M0 stomach carcinoma].
Hehr T; Adamek HE
Strahlenther Onkol; 2002 Mar; 178(3):164-6. PubMed ID: 11962195
[No Abstract] [Full Text] [Related]
6. Neoadjuvant chemotherapy, radical resection with intraoperative radiation therapy (IORT): improved treatment for gastric adenocarcinoma.
Weese JL; Harbison SP; Stiller GD; Henry DH; Fisher SA
Surgery; 2000 Oct; 128(4):564-71. PubMed ID: 11015089
[TBL] [Abstract][Full Text] [Related]
7. The treatment of advanced gastric cancer.
Wils J
Semin Oncol; 1996 Jun; 23(3):397-406. PubMed ID: 8658224
[TBL] [Abstract][Full Text] [Related]
8. Combination 5-fluoruracil/cisplatinum versus 5-fluoruracil/leucovorin adjuvant chemotherapy efficacy for R0 gastric resection in locally invasive gastric cancer.
Yamada S; Ritchim P; Charkrabandhu T; Jongraksat W
J Med Assoc Thai; 2012 Dec; 95(12):1517-23. PubMed ID: 23390781
[TBL] [Abstract][Full Text] [Related]
9. Gastric adenocarcinoma treated with R0-R1 surgical resection and intraoperative radiotherapy (IORT) plus external beam radiation therapy (EBRT).
Glehen O; Beaujard AC; Romestaing P; Sentenac I; Francois Y; Peyrat P; Braillon G; Vignal J; Gérard JP; Gilly FN
Suppl Tumori; 2003; 2(5):S51-3. PubMed ID: 12914392
[No Abstract] [Full Text] [Related]
10. Current status of adjuvant therapy for colorectal cancer.
O'Connell MJ
Oncology (Williston Park); 2004 May; 18(6):751-5; discussion 755-8. PubMed ID: 15214594
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma.
Fu S; Lu JJ; Zhang Q; Yang Z; Peng L; Xiong F
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1488-94. PubMed ID: 18538489
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of current adjuvant and neoadjuvant therapeutic concepts in gastric cancer?].
Kretzschmar A; Schlag PM
Zentralbl Chir; 2006 Apr; 131(2):121-5. PubMed ID: 16612778
[TBL] [Abstract][Full Text] [Related]
13. The UK NCRI MAGIC trial of perioperative chemotherapy in resectable gastric cancer: implications for clinical practice.
Chua YJ; Cunningham D
Ann Surg Oncol; 2007 Oct; 14(10):2687-90. PubMed ID: 17653804
[No Abstract] [Full Text] [Related]
14. Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer.
Briasoulis E; Liakakos T; Dova L; Fatouros M; Tsekeris P; Roukos DH; Kappas AM
Expert Rev Anticancer Ther; 2006 Jun; 6(6):931-9. PubMed ID: 16761937
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant and neoadjuvant approaches in gastric cancer.
Ng K; Meyerhardt JA; Fuchs CS
Cancer J; 2007; 13(3):168-74. PubMed ID: 17620766
[TBL] [Abstract][Full Text] [Related]
16. Role of post-operative chemoradiation in resected gastric cancer.
Macdonald JS
J Surg Oncol; 2005 Jun; 90(3):166-70. PubMed ID: 15895449
[TBL] [Abstract][Full Text] [Related]
17. Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?
Briasoulis E; Fatouros M; Roukos DH
Ann Surg Oncol; 2007 Oct; 14(10):2691-5. PubMed ID: 17653806
[No Abstract] [Full Text] [Related]
18. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy for gastric cancer or not: a dilemma?
Wu A; Ji J
J Natl Cancer Inst; 2008 Mar; 100(6):376-7. PubMed ID: 18334705
[No Abstract] [Full Text] [Related]
20. A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy.
Yu W
Eur J Surg Oncol; 2006 Aug; 32(6):655-60. PubMed ID: 16618532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
